Milk Thistle Clinical Trial in Pediatric NAFLD
NCT06477146
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Pediatric Fatty Liver disease is a growing problem in the United States and is expected to be the leading cause of Liver Transplantation in Adults in 20 years. Following lifestyle changes such as diet restrictions and exercise may be difficult to consistently maintain. The purpose of this study is to investigate alternative medical therapy with an herbal supplement called Milk Thistle (MT) which may improve fatty liver disease and would be easier to follow than diet and exercise.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Non-Alcoholic Fatty Liver Disease (NAFLD)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 9 to 22 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- University Hospitals Cleveland Medical Center
- Last updated on ClinicalTrials.gov
- January 27, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Ohio · 1
- University Hospitals Cleveland Medical Center · Cleveland, OH
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.